Your browser doesn't support javascript.
loading
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failure.
Mentz, Robert J; Xu, Haolin; O'Brien, Emily C; Thomas, Laine; Alexy, Tamas; Gupta, Bhanu; Vilaro, Juan; Lala, Anuradha; DeVore, Adam D; Dhingra, Ravi; Briasoulis, Alexandros; Simon, Marc A; Stehlik, Josef; Rodgers, Jo E; Dunlay, Shannon M; Abshire, Martha; Wells, Quinn S; Barringhaus, Kurt G; Eckman, Peter M; Lowes, Brian D; Espinoza, Johana; Blanco, Rosalia; Shen, Xian; Duffy, Carol I; Hernandez, Adrian F.
Afiliación
  • Mentz RJ; Duke Clinical Research Institute, Durham, NC; Duke University School of Medicine, Durham, NC. Electronic address: robert.mentz@duke.edu.
  • Xu H; Duke Clinical Research Institute, Durham, NC.
  • O'Brien EC; Duke Clinical Research Institute, Durham, NC.
  • Thomas L; Duke Clinical Research Institute, Durham, NC.
  • Alexy T; University of Minnesota Health, Minneapolis, MN.
  • Gupta B; University of Kansas Medical Center, Kansas City, KS.
  • Vilaro J; University of Florida, Gainesville, FL.
  • Lala A; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • DeVore AD; Duke Clinical Research Institute, Durham, NC; Duke University School of Medicine, Durham, NC.
  • Dhingra R; University of Wisconsin, Madison, WI.
  • Briasoulis A; University of Iowa Hospitals and Clinics, Iowa City, IA.
  • Simon MA; Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, McGowan Institute for Regenerative Medicine, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA.
  • Stehlik J; University of Utah School of Medicine, Salt Lake City, UT.
  • Rodgers JE; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Dunlay SM; Mayo Clinic, Rochester, MN.
  • Abshire M; Johns Hopkins School of Nursing, Baltimore, MD.
  • Wells QS; Vanderbilt University Medical Center, Nashville, TN.
  • Barringhaus KG; University of South Carolina School of Medicine and WJB Dorn Veteran Affairs Medical Center, Columbia, SC.
  • Eckman PM; Minneapolis Heart Institute; Minneapolis, MN.
  • Lowes BD; University of Nebraska Medical Center, Omaha, NE.
  • Espinoza J; Duke Clinical Research Institute, Durham, NC.
  • Blanco R; Duke Clinical Research Institute, Durham, NC.
  • Shen X; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Duffy CI; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Hernandez AF; Duke Clinical Research Institute, Durham, NC; Duke University School of Medicine, Durham, NC.
Am Heart J ; 230: 35-43, 2020 12.
Article en En | MEDLINE | ID: mdl-32980364
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Tetrazoles / Medición de Resultados Informados por el Paciente / Datos Preliminares / Aminobutiratos / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Tetrazoles / Medición de Resultados Informados por el Paciente / Datos Preliminares / Aminobutiratos / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos